GB9613183D0 - Effervescent alendronate formulation - Google Patents

Effervescent alendronate formulation

Info

Publication number
GB9613183D0
GB9613183D0 GBGB9613183.4A GB9613183A GB9613183D0 GB 9613183 D0 GB9613183 D0 GB 9613183D0 GB 9613183 A GB9613183 A GB 9613183A GB 9613183 D0 GB9613183 D0 GB 9613183D0
Authority
GB
United Kingdom
Prior art keywords
effervescent
alendronate formulation
formulation
effervescent alendronate
alendronate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9613183.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GBGB9613183.4A priority Critical patent/GB9613183D0/en
Publication of GB9613183D0 publication Critical patent/GB9613183D0/en
Priority to EP97924695A priority patent/EP0939624B1/en
Priority to DE69726879T priority patent/DE69726879T2/en
Priority to PCT/US1997/008055 priority patent/WO1997044017A1/en
Priority to AT97924695T priority patent/ATE256456T1/en
Priority to ES97924695T priority patent/ES2210529T3/en
Priority to EP07009020A priority patent/EP1820497A3/en
Priority to CA002254060A priority patent/CA2254060C/en
Priority to AU30053/97A priority patent/AU712710B2/en
Priority to EP03077124A priority patent/EP1378234A1/en
Priority to JP09542490A priority patent/JP2000511178A/en
Priority to HK99104703A priority patent/HK1019555A1/en
Priority to JP2009063857A priority patent/JP2009167200A/en
Pending legal-status Critical Current

Links

GBGB9613183.4A 1996-05-17 1996-06-24 Effervescent alendronate formulation Pending GB9613183D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB9613183.4A GB9613183D0 (en) 1996-06-24 1996-06-24 Effervescent alendronate formulation
JP09542490A JP2000511178A (en) 1996-05-17 1997-05-13 Effervescent bisphosphonate preparation
EP07009020A EP1820497A3 (en) 1996-05-17 1997-05-13 Effervescent bisphosphonate formulation
DE69726879T DE69726879T2 (en) 1996-05-17 1997-05-13 BIPHOSPHONATE FORMULATION WITH EFFECT
PCT/US1997/008055 WO1997044017A1 (en) 1996-05-17 1997-05-13 Effervescent bisphosphonate formulation
AT97924695T ATE256456T1 (en) 1996-05-17 1997-05-13 BIPHOSPHONATE FORMULATION WITH EFFORTABLE EFFECT
ES97924695T ES2210529T3 (en) 1996-05-17 1997-05-13 FORMULATION OF EFFERVESCENT BISPHOSPHONATE.
EP97924695A EP0939624B1 (en) 1996-05-17 1997-05-13 Effervescent bisphosphonate formulation
CA002254060A CA2254060C (en) 1996-05-17 1997-05-13 Effervescent bisphosphonate formulation
AU30053/97A AU712710B2 (en) 1996-05-17 1997-05-13 Effervescent bisphosphonate formulation
EP03077124A EP1378234A1 (en) 1996-05-17 1997-05-13 Effervescent bisphosphonate formulation
HK99104703A HK1019555A1 (en) 1996-05-17 1999-10-22 Effervescent bisphosphonate formulation
JP2009063857A JP2009167200A (en) 1996-05-17 2009-03-17 Effervescent bisphosphonate formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9613183.4A GB9613183D0 (en) 1996-06-24 1996-06-24 Effervescent alendronate formulation

Publications (1)

Publication Number Publication Date
GB9613183D0 true GB9613183D0 (en) 1996-08-28

Family

ID=10795776

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9613183.4A Pending GB9613183D0 (en) 1996-05-17 1996-06-24 Effervescent alendronate formulation

Country Status (1)

Country Link
GB (1) GB9613183D0 (en)

Similar Documents

Publication Publication Date Title
ZA974207B (en) Effervescent bisphosphonate formulation.
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
ZA974486B (en) Concentrated antibody formulation
ZA9710601B (en) Novel formulation
HUP0004665A3 (en) Anaesthetic formulation
IL129127A0 (en) Liquid alendronate formulations
GB9724544D0 (en) Novel Formulation
GB2307857B (en) An effervescent formulation
GB9725061D0 (en) Revitalisation formulation
GB9706957D0 (en) Formulation
ZA976592B (en) Formulation
GB9613183D0 (en) Effervescent alendronate formulation
GB9509291D0 (en) Formulations
HU9602732D0 (en) Lanperisone formulation
GB9404989D0 (en) Lipomimetric formulation
GB9725275D0 (en) Formulation
GB9721807D0 (en) Formulation
GB9602950D0 (en) Pesticidal formulation
GB9621749D0 (en) Pharmaceutical combination formulation
GB9603141D0 (en) Pharmaceutical formulation
GB9412641D0 (en) Formulation
GB9423416D0 (en) Formulation
GB9412642D0 (en) Formulation
GB9416500D0 (en) Formulation
ZA952272B (en) Formulation